Objective - The new method TISA was used to evaluate Losigamone efficacy. M
ethods - Sixteen patients with pharmacoresistant partial seizures undergoin
g presurgical evaluation were randomized in this double-blind, placebo-con
trolled, parallel-group Losigamone monotherapy study under continuous video
-EEG monitoring. Duration (in s, of each seizure and each ictal sign), inte
nsity (grade zero to three), N/24 h (number of seizures and ictal signs per
24 h), D/24 h (seconds per 24 h covered by seizures and ictal signs) and s
eizure free intervals were recorded. Results - A total of 246 seizures were
intensively analyzed. The duration and intensity of all seizures improved
more in the active treatment group than in the placebo group. There was a s
tatistically significant superiority in the duration of the seizure free in
terval in the Losigamone group. Ictal signs such as oro-alimentary automati
sms and fumbling were improved during Losigamone treatment. Conclusion - Lo
sigamone has a preferred inhibitory effect on propagated epileptic activity
. TISA is a sensitive method for evaluation of the selective effects of AED
s.